Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
21%
ALSO IN IBRN
IBRN
60
HOLDINGS
15%
ALSO IN PBE
SECTOR DRIFT (PBE minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 5.5% | 4.3% | 4.3% |
|
PTC THERAPEUTICS INC | 3.4% | 4.8% | 3.4% |
|
CATALYST PHARMACEUTICAL PART | 2.7% | 3.9% | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% | 3.4% | 2.6% |
|
SAREPTA THERAPEUTICS INC | 3.2% | 2.5% | 2.5% |
PBE Overweight Relative to IBRN
|
VERTEX PHARMACEUTICALS INC | 4.9% |
|
ILLUMINA INC | 4.8% |
|
INCYTE CORP | 4.8% |
|
AMGEN INC | 4.8% |
|
REGENERON PHARMACEUTICALS | 4.8% |
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
GILEAD SCIENCES INC | 4.6% |
|
IONIS PHARMACEUTICALS, INC. | 4.2% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
VERACYTE INC | 3.2% |
PBE Underweight Relative to IBRN
|
SCHOLAR ROCK HOLDING CORP. | -4.5% |
 |
ARGENX SE ADR | -4.3% |
|
AXSOME THERAPEUTICS, INC. | -4.2% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.6% |
|
DYNE THERAPEUTICS INC | -3.5% |
|
DENALI THERAPEUTICS INC. | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.4% |
 |
ALKERMES PLC | -3.3% |
|
EDGEWISE THERAPEUTICS, INC. | -2.6% |
|
AXOGEN, INC. | -1.8% |